share_log

Nova Leap Health Corp. Enters Into Term Sheet to Amend Its Credit Agreement for up to an Additional $7 Million to Support Continued Growth

Nova Leap Health Corp. Enters Into Term Sheet to Amend Its Credit Agreement for up to an Additional $7 Million to Support Continued Growth

nova Leap Health corp. 签署条款清单,以修改其信贷协议,增至额外700万美元以支持持续增长。
GlobeNewswire ·  11/27 06:30

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

未经美国本土新闻电线服务传播或分发。

HALIFAX, Nova Scotia, Nov. 26, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has entered into an agreement to amend its existing credit agreement (the "Credit Agreement") with BMO Bank of Montreal for new credit facilities (the "Credit Facilities"). The amended Credit Agreement will provide up to an additional $7 million of available credit to support the Company's long-term growth strategy. All amounts are in United States dollars unless otherwise specified.

新斯科舍省哈利法克斯,2024年11月26日(环球新闻)- NOVA LEAP HEALTH CORP.(TSXV: NLH)(“Nova Leap”或“公司”),一家不断增长的家庭医疗保健组织,很高兴宣布已与蒙特利尔银行(BMO Bank of Montreal)就新信贷工具(“信贷工具”)的现有信贷协议(“信贷协议”)进行修订达成协议。修订后的信贷协议将提供多达额外700万美元的可用信贷,以支持公司的长期增长策略。除非另有说明,所有金额均以美元计算。

The Credit Facilities consist of non-readvanceable demand acquisition lines to assist with business acquisitions, including the Nova Scotia acquisition announced on October 29, 2024, the Florida acquisition announced on October 15, 2024, and future business acquisitions approved by the lender, in addition to the Company's existing facilities for working capital and day-to-day operating needs. The acquisition lines are available as CAD prime (prime rate plus 1.50%) and USD base rate (base rate plus 1.50%) loans, as well as fixed rate loans with rates determined at the time of booking.

信贷工具包括不可再借的需求获取信贷额,用于业务收购,包括已于2024年10月29日宣布的新斯科舍省收购,于2024年10月15日宣布的佛罗里达州收购,以及由贷款人批准的未来业务收购,另外还包括公司现有的为营运资金和日常运营需求提供的信贷额。这些收购额可以作为加拿大元基准利率(基准利率加1.50%)和美元基准利率(基准利率加1.50%)贷款,以及根据预订时间确定利率的固定利率贷款。

The Credit Facilities contain financial and other covenants and security in favour of the lender which are customary for facilities of this nature, including security over the assets of the Company and its subsidiaries, and are conditional upon obtaining coverage under Export Development Canada's Export Guarantee Program.

信贷工具包含适用于此类信贷工具的财务和其他契约以及有利于贷款人的担保,包括对公司及其子公司资产的担保,并且须获得加拿大出口发展公司(Export Development Canada)的出口担保计划的保险才能生效。

Management Comments

管理层评论

"We are pleased to secure the new Credit Facilities. Our ability to complete this transaction reflects the consistent cash flow and financial results that we have produced. With our strong Adjusted EBITDA over the past six quarters, our capital structure can comfortably support increased debt, while still maintaining financial flexibility," said Chris LeBlanc, Chief Financial Officer of Nova Leap.

我们很高兴获得新的信贷额度。我们成功完成这笔交易的能力反映了我们产生的持续现金流和财务业绩。根据过去六个季度的强劲调整后的税息折旧及摊销前利润,我们的资本结构可以轻松支持增加债务,同时保持财务灵活性,"nova首席财务官Chris LeBlanc表示。

"The successful negotiation of the Credit Facilities provides us with greater financial flexibility to execute on our growth strategy that consists of investing in our business to drive organic growth and in pursuing strategic acquisitions," said Chris Dobbin, President & CEO of Nova Leap.

成功谈判信贷额度为我们提供了更大的财务灵活性,以执行我们的增长策略,包括投资于业务以推动有机增长并追求战略收购,"nova首席执行官Chris Dobbin表示。

About Nova Leap

关于Nova Leap

Nova Leap is an acquisitive home health care services company operating in one of the fastest-growing industries in the U.S. & Canada. The Company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved the #42 ranking on the 2021 Report on Business ranking of Canada's Top Growing Companies, the #2 ranking on the 2020 Report on Business ranking of Canada's Top Growing Companies and the #10 Ranking in the 2019 TSX Venture 50 in the Clean Technology & Life Sciences sector. The Company is geographically diversified with operations in 10 different U.S. states within the New England, Southeastern, South Central and Midwest regions as well as in Nova Scotia, Canada.

Nova Leap是一家收购型家庭医疗保健服务公司,在美国和加拿大增长最快的行业之一进行运营。公司在关注个人和家庭的基础上扮演着至关重要的角色,特别是那些需要痴呆症护理的人。Nova Leap在加拿大2021年Ranking of Canada's Top Growing Companies排名第42,在2020年Ranking of Canada's Top Growing Companies排名第2,在2019年TSX Venture 50中排名第10,属于清洁技术和生命科学板块。该公司业务遍布新英格兰、东南部、南部和中西部等10个美国州,以及加拿大新斯科舍。

NON-IFRS MEASURES:

非IFRS衡量标准:

This release contains references to certain measures that do not have a standardized meaning under IFRS as prescribed by the International Accounting Standards Board ("IASB") and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement IFRS measures by providing a further understanding of operations from management's perspective. Accordingly, non-IFRS financial measures should not be considered in isolation or as a substitute for analysis of financial information reported under IFRS. The Company presents non-IFRS financial measures, specifically Adjusted EBITDA (as such term is hereinafter defined), as well as supplementary financial measures such as annualized revenue and annualized adjusted EBITDA. The Company believes these non-IFRS financial measures are frequently used by lenders, securities analysts, investors and other interested parties as a measure of financial performance, and it is therefore helpful to provide supplemental measures of operating performance and thus highlight trends that may not otherwise be apparent when relying solely on IFRS financial measures.

本报告涉及某些措施,这些措施在国际会计准则理事会("IASB")规定的IFRS下没有标准化的含义,因此可能不适合与其他公司提供的类似措施进行比较。相反,这些措施作为补充信息提供,以补充IFRS措施,从管理角度提供进一步的运营理解。因此,不应将非IFRS财务措施作为孤立的分析或替代IFRS下报告的财务信息。公司提供非IFRS财务措施,特别是调整后EBITDA(如下文所定义),以及年化营业收入和年化调整后EBITDA等补充财务措施。公司认为,这些非IFRS财务措施经常被放贷人、证券分析师、投资者和其他感兴趣的各方用作衡量财务业绩的指标,因此提供运营绩效的补充措施,并突出当仅依靠IFRS财务措施时可能不明显的趋势。

Adjusted Earnings before interest, taxes, amortization and depreciation ("Adjusted EBITDA"), is calculated as income from operating activities plus amortization and depreciation and stock-based compensation expense. The most directly comparable IFRS measure is income from operating activities.

经营性收益加上摊销和折旧以及股票补偿费用,即为调整后的息税前利润("调整后的EBITDA")计算方法。最直接可比的IFRS衡量指标为经营性收益。

FORWARD LOOKING INFORMATION:

前瞻性信息:

Certain information in this press release may contain forward-looking statements, such as statements regarding availability of the Credit Facilities, the closing of the acquisitions (including timing) and its expected impact on the Company, financing of the acquisitions, and plans regarding future acquisitions and business growth. This information is based on current expectations and assumptions, including assumptions described elsewhere in this release and those concerning general economic and market conditions, the satisfaction of conditions to closing the Credit Facilities and the acquisitions, availability of working capital necessary for conducting Nova Leap's operations, availability of desirable acquisition targets and financing to fund such acquisitions, and Nova Leap's ability to integrate its acquired businesses and maintain previously achieved service hour and revenue levels, that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. Risks that could cause results to differ from those stated in the forward-looking statements in this release include staff and supply shortages, regulatory changes affecting the home care industry or government programs utilized by the Company, other unexpected increases in operating costs and competition from other service providers. All forward-looking statements, including any financial outlook or future-oriented financial information, contained in this press release are made as of the date of this release and included for the purpose of providing information about management's current expectations and plans relating to the future, and these statements may not be appropriate for other purposes. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company's filings with the Canadian securities regulators, which filings are available at .

本新闻稿中的某些信息可能包含前瞻性陈述,如有关信贷额度可用性、收购的完成(包括时间安排)以及对公司预期影响、收购的融资、未来收购和业务增长计划的陈述。这些信息基于目前的期望和假设,包括本新闻稿中描述的假设和关于一般经济和市场情况、符合信贷额度和收购完成条件、为Nova Leap运营提供必要的营运资本、提供理想收购目标和融资以资助此类收购的可用性,以及Nova Leap整合已收购业务并保持先前达到的服务小时和营收水平的能力等等假设,这些假设都面临着难以预测的重大风险和不确定性。实际结果可能与任何前瞻性陈述中暗示的结果有很大不同。可能导致结果与本新闻稿中前瞻性陈述中所述结果不同的风险包括员工和供应短缺、影响公司所利用的家庭护理行业或政府方案的监管变化、其他意外的运营成本增加以及与其他服务提供商的竞争。本新闻稿中包含的所有前瞻性陈述,包括任何财务展望或未来导向的财务信息,均截至本新闻稿日期为止,并仅用于提供有关管理层当前的期望和未来计划的信息,这些陈述可能不适用于其他目的。除非要求公司遵守适用于公司的证券法规定,否则公司不承担更新前瞻性陈述或更新导致实际结果可能与前瞻性陈述中反映的结果不同的原因的义务。包含在加拿大证券监管机构备案文件中的标识风险和不确定性的额外信息,请参阅该等备案文件。 .

CAUTIONARY STATEMENT:

警示声明:

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

TSX tsx Venture交易所及其监管服务提供商(如TSX Venture交易所的政策中所定义的那样)不承担此发布的充分性或准确性的责任。

CONTACT: For further information:

Chris Dobbin, CPA, ICD.D
Director, President and CEO
Nova Leap Health Corp.
E:cdobbin@novaleaphealth.com
联系人: 欲获得更多信息:

Chris Dobbin,注册会计师,ICD.D
董事、总裁兼首席执行官
nova医疗保健公司。
E: cdobbin@novaleaphealth.com

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发